Abstract
In a number of genetic disorders such as GNE myopathy, it is not clear how mutations in target genes result in disease phenotype. GNE myopathy is a progressive neuro-degenerative disorder associated with homozygous or compound heterozygous missense mutations in either epimerase or kinase domain of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE). This bifunctional enzyme catalyses the rate limiting step in sialic acid biosynthesis. Many mechanisms have been suggested as possible cause of muscle degeneration. These include hyposialylation of critical proteins, defects in cytoskeletal network, sarcomere organization and apoptosis. In order to elucidate the role of GNE in cell apoptosis, we have used HEK cell-based model system overexpressing pathologically relevant GNE mutations. These cells display a reduction in the levels of sialic acid-bound glycoconjugates. These mutants GNE overexpressing cells have defect in cell proliferation as compared to vector or wild-type GNE (wtGNE) controls. Moreover, effect of different GNE mutations on cell apoptosis was also observed using staining with annexin V-FITC and TUNEL assay. The downstream apoptosis signalling pathway involving activation of caspases and increased PARP cleavage were observed in all GNE mutant cell lines. In addition, morpho-structural changes in mitochondria in cells overexpressing different GNE mutants were noticed by transmission electron microscopy, and mitochondrial transmembrane potential was found to be altered in absence of functional GNE. Our results clearly indicate role of GNE in mitochondria-dependent cell apoptosis and provide insights into the pathomechanism of GNE myopathy.
Similar content being viewed by others
References
Severi E, Hood DW, Thomas GH (2007) Sialic acid utilization by bacterial pathogens. Microbiology 153(Pt 9):2817–2822. doi:10.1099/mic.0.2007/009480-0
Frenzel R, Krohn K, Eszlinger M, Tonjes A, Paschke R (2005) Sialylation of human thyrotropin receptor improves and prolongs its cell-surface expression. Mol Pharmacol 68(4):1106–1113. doi:10.1124/mol.105.012906
Edelman GM, Crossin KL (1991) Cell adhesion molecules: implications for a molecular histology. Annu Rev Biochem 60:155–190. doi:10.1146/annurev.bi.60.070191.001103
Narayanan S (1994) Sialic acid as a tumor marker. Ann Clin Lab Sci 24(4):376–384
Wielgat P, Braszko JJ (2012) Significance of the cell adhesion molecules and sialic acid in neurodegeneration. Adv Med Sci 57(1):23–30. doi:10.2478/v10039-012-0011-0
Prajna K, Kumar JA, Rai S, Shetty SK, Rai T, Shrinidhi, Begum M, Shashikala MD (2013) Predictive value of serum sialic Acid in type-2 diabetes mellitus and its complication (nephropathy). J Clin Diagn Res 7(11):2435–2437. doi:10.7860/JCDR/2013/6210.3567
Ito M, Sugihara K, Asaka T, Toyama T, Yoshihara T, Furuichi K, Wada T, Asano M (2012) Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice. PLoS One 7(1):e29873. doi:10.1371/journal.pone.0029873
Valles-Ayoub Y, Esfandiarifard S, Sinai P, Carbajo R, Khokher Z, No D, Pietruszka M, Darvish B et al (2012) Serum neural cell adhesion molecule is hyposialylated in hereditary inclusion body myopathy. Genet Test Mol Biomarkers 16(5):313–317. doi:10.1089/gtmb.2011.0146
Huizing M, Krasnewich DM (2009) Hereditary inclusion body myopathy: a decade of progress. Biochim Biophys Acta 1792(9):881–887. doi:10.1016/j.bbadis.2009.07.001
Hinderlich S, Weidemann W, Yardeni T, Horstkorte R, Huizing M (2013) UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): a Master Regulator of Sialic Acid Synthesis. Top Curr Chem. doi:10.1007/128_2013_464
Leroy JG, Seppala R, Huizing M, Dacremont G, De Simpel H, Van Coster RN, Orvisky E, Krasnewich DM et al (2001) Dominant inheritance of sialuria, an inborn error of feedback inhibition. Am J Hum Genet 68(6):1419–1427. doi:10.1086/320598
Ghaderi D, Strauss HM, Reinke S, Cirak S, Reutter W, Lucka L, Hinderlich S (2007) Evidence for dynamic interplay of different oligomeric states of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase by biophysical methods. J Mol Biol 369(3):746–758. doi:10.1016/j.jmb.2007.03.037
Tong Y, Tempel W, Nedyalkova L, Mackenzie F, Park HW (2009) Crystal structure of the N-acetylmannosamine kinase domain of GNE. PLoS One 4(10):e7165. doi:10.1371/journal.pone.0007165
Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, Barash M, Shemesh M et al (2001) The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 29(1):83–87. doi:10.1038/ng718
Seppala R, Tietze F, Krasnewich D, Weiss P, Ashwell G, Barsh G, Thomas GH, Packman S et al (1991) Sialic acid metabolism in sialuria fibroblasts. J Biol Chem 266(12):7456–7461
Mori-Yoshimura M, Monma K, Suzuki N, Aoki M, Kumamoto T, Tanaka K, Tomimitsu H, Nakano S et al (2012) Heterozygous UDP-GlcNAc 2-epimerase and N-acetylmannosamine kinase domain mutations in the GNE gene result in a less severe GNE myopathy phenotype compared to homozygous N-acetylmannosamine kinase domain mutations. J Neurol Sci 318(1-2):100–105. doi:10.1016/j.jns.2012.03.016
Galeano B, Klootwijk R, Manoli I, Sun M, Ciccone C, Darvish D, Starost MF, Zerfas PM et al (2007) Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest 117(6):1585–1594. doi:10.1172/JCI30954
Eisenberg I, Grabov-Nardini G, Hochner H, Korner M, Sadeh M, Bertorini T, Bushby K, Castellan C et al (2003) Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps. Hum Mutat 21(1):99. doi:10.1002/humu.9100
Tanboon J, Rongsa K, Pithukpakorn M, Boonyapisit K, Limwongse C, Sangruchi T (2014) A Novel Mutation of the GNE Gene in Distal Myopathy with Rimmed Vacuoles: a Case with Inflammation. Case Rep Neurol 6(1):55–59. doi:10.1159/000360730
Nalini A, Gayathri N, Nishino I, Hayashi YK (2013) GNE myopathy in India. Neurol India 61(4):371–374. doi:10.4103/0028-3886.117609
Huizing M, Carrillo-Carrasco N, Malicdan MC, Noguchi S, Gahl WA, Mitrani-Rosenbaum S, Argov Z, Nishino I (2014) GNE myopathy: new name and new mutation nomenclature. Neuromuscul Disord 24(5):387–389. doi:10.1016/j.nmd.2014.03.004
Park YE, Kim HS, Choi ES, Shin JH, Kim SY, Son EH, Lee CH, Kim DS (2012) Limb-girdle phenotype is frequent in patients with myopathy associated with GNE mutations. J Neurol Sci 321(1-2):77–81. doi:10.1016/j.jns.2012.07.061
Celeste FV, Vilboux T, Ciccone C, de Dios JK, Malicdan MC, Leoyklang P, McKew JC, Gahl WA et al (2014) Mutation Update for GNE Gene Variants Associated with GNE Myopathy. Hum Mutat 35(8):915–926. doi:10.1002/humu.22583
Cho A, Hayashi YK, Monma K, Oya Y, Noguchi S, Nonaka I, Nishino I (2014) Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy). J Neurol Neurosurg Psychiatry 85(8):914–917. doi:10.1136/jnnp-2013-305587
Grover S, Arya R (2014) Role of UDP-N-Acetylglucosamine2-Epimerase/N-Acetylmannosamine Kinase (GNE) in beta1-Integrin-Mediated Cell Adhesion. Mol Neurobiol. doi:10.1007/s12035-013-8604-6
Amsili S, Zer H, Hinderlich S, Krause S, Becker-Cohen M, MacArthur DG, North KN, Mitrani-Rosenbaum S (2008) UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) binds to alpha-actinin 1: novel pathways in skeletal muscle? PLoS One 3(6):e2477. doi:10.1371/journal.pone.0002477
Sela I, Milman Krentsis I, Shlomai Z, Sadeh M, Dabby R, Argov Z, Ben-Bassat H, Mitrani-Rosenbaum S (2011) The proteomic profile of hereditary inclusion body myopathy. PLoS One 6(1):e16334. doi:10.1371/journal.pone.0016334
Weidemann W, Stelzl U, Lisewski U, Bork K, Wanker EE, Hinderlich S, Horstkorte R (2006) The collapsin response mediator protein 1 (CRMP-1) and the promyelocytic leukemia zinc finger protein (PLZF) bind to UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE), the key enzyme of sialic acid biosynthesis. FEBS Lett 580(28-29):6649–6654. doi:10.1016/j.febslet.2006.11.015
Weidemann W, Klukas C, Klein A, Simm A, Schreiber F, Horstkorte R (2010) Lessons from GNE-deficient embryonic stem cells: sialic acid biosynthesis is involved in proliferation and gene expression. Glycobiology 20(1):107–117. doi:10.1093/glycob/cwp153
Wang Z, Sun Z, Li AV, Yarema KJ (2006) Roles for UDP-GlcNAc 2-epimerase/ManNAc 6-kinase outside of sialic acid biosynthesis: modulation of sialyltransferase and BiP expression, GM3 and GD3 biosynthesis, proliferation, and apoptosis, and ERK1/2 phosphorylation. J Biol Chem 281(37):27016–27028. doi:10.1074/jbc.M604903200
Kemmner W, Kessel P, Sanchez-Ruderisch H, Moller H, Hinderlich S, Schlag PM, Detjen K (2012) Loss of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) induces apoptotic processes in pancreatic carcinoma cells. FASEB J 26(2):938–946. doi:10.1096/fj.11-186700
Jiang X, Wang X (2004) Cytochrome C-mediated apoptosis. Annu Rev Biochem 73:87–106. doi:10.1146/annurev.biochem.73.011303.073706
Cosentino K, Garcia-Saez AJ (2014) Mitochondrial alterations in apoptosis. Chem Phys Lipids 181:62–75. doi:10.1016/j.chemphyslip.2014.04.001
Eisenberg I, Novershtern N, Itzhaki Z, Becker-Cohen M, Sadeh M, Willems PH, Friedman N, Koopman WJ et al (2008) Mitochondrial processes are impaired in hereditary inclusion body myopathy. Hum Mol Genet 17(23):3663–3674. doi:10.1093/hmg/ddn261
Amsili S, Shlomai Z, Levitzki R, Krause S, Lochmuller H, Ben-Bassat H, Mitrani-Rosenbaum S (2007) Characterization of hereditary inclusion body myopathy myoblasts: possible primary impairment of apoptotic events. Cell Death Differ 14(11):1916–1924. doi:10.1038/sj.cdd.4402208
Arabkhari M, Bunda S, Wang Y, Wang A, Pshezhetsky AV, Hinek A (2010) Desialylation of insulin receptors and IGF-1 receptors by neuraminidase-1 controls the net proliferative response of L6 myoblasts to insulin. Glycobiology 20(5):603–616. doi:10.1093/glycob/cwq010
Gu J, Zhou S, Ding R, Aizezi W, Jiang A, Chen J (2013) Necrotizing scleritis and peripheral ulcerative keratitis associated with Wegener's granulomatosis. Ophthalmol Ther 2(2):99–111. doi:10.1007/s40123-013-0016-1
Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R et al (2003) Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. Cancer Res 63(1):93–99
Berger NA (1985) Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 101(1):4–15
Smith L, Wang Z, Smith JB (2003) Caspase processing activates atypical protein kinase C zeta by relieving autoinhibition and destabilizes the protein. Biochem J 375(Pt 3):663–671. doi:10.1042/BJ20030926
Broccolini A, Mirabella M (2014) Hereditary inclusion-body myopathies. Biochim Biophys Acta. doi:10.1016/j.bbadis.2014.08.007
Li H, Chen Q, Liu F, Zhang X, Li W, Liu S, Zhao Y, Gong Y et al (2013) Unfolded protein response and activated degradative pathways regulation in GNE myopathy. PLoS One 8(3):e58116. doi:10.1371/journal.pone.0058116
Fischer C, Kleinschnitz K, Wrede A, Muth I, Kruse N, Nishino I, Schmidt J (2013) Cell stress molecules in the skeletal muscle of GNE myopathy. BMC Neurol 13:24. doi:10.1186/1471-2377-13-24
Malicdan MC, Noguchi S, Nonaka I, Hayashi YK, Nishino I (2007) A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 16(22):2669–2682. doi:10.1093/hmg/ddm220
Malicdan MC, Noguchi S, Nonaka I, Hayashi YK, Nishino I (2007) A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 16(2):115–128. doi:10.1093/hmg/ddl446
Malicdan MC, Noguchi S, Hayashi YK, Nonaka I, Nishino I (2009) Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 15(6):690–695. doi:10.1038/nm.1956
Schwarzkopf M, Knobeloch KP, Rohde E, Hinderlich S, Wiechens N, Lucka L, Horak I, Reutter W et al (2002) Sialylation is essential for early development in mice. Proc Natl Acad Sci U S A 99(8):5267–5270. doi:10.1073/pnas.072066199
Daya A, Vatine GD, Becker-Cohen M, Tal-Goldberg T, Friedmann A, Gothilf Y, Du SJ, Mitrani-Rosenbaum S (2014) Gne depletion during zebrafish development impairs skeletal muscle structure and function. Hum Mol Genet 23(13):3349–3361. doi:10.1093/hmg/ddu045
Salama I, Hinderlich S, Shlomai Z, Eisenberg I, Krause S, Yarema K, Argov Z, Lochmuller H et al (2005) No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation. Biochem Biophys Res Commun 328(1):221–226. doi:10.1016/j.bbrc.2004.12.157
Weidemann W, Reinhardt A, Thate A, Horstkorte R (2011) Biochemical characterization of the M712T-mutation of the UDP-N-acetylglucosamine 2-epimerase/N-acetyl-mannosaminekinase in hereditary inclusion body myopathy. Neuromuscul Disord 21(12):824–831. doi:10.1016/j.nmd.2011.06.004
Paccalet T, Coulombe Z, Tremblay JP (2010) Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease. PLoS One 5(4):e10055. doi:10.1371/journal.pone.0010055
Bork K, Reutter W, Weidemann W, Horstkorte R (2007) Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase/ManAc kinase containing a sialuria mutation in CHO cells. FEBS Lett 581(22):4195–4198. doi:10.1016/j.febslet.2007.07.060
Kontou M, Weidemann W, Bork K, Horstkorte R (2009) Beyond glycosylation: sialic acid precursors act as signaling molecules and are involved in cellular control of differentiation of PC12 cells. Biol Chem 390(7):575–579. doi:10.1515/BC.2009.058
Fulda S, Debatin KM (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25(34):4798–4811. doi:10.1038/sj.onc.1209608
Filosto M, Scarpelli M, Cotelli MS, Vielmi V, Todeschini A, Gregorelli V, Tonin P, Tomelleri G et al (2011) The role of mitochondria in neurodegenerative diseases. J Neurol 258(10):1763–1774. doi:10.1007/s00415-011-6104-z
Kang SU, Cho JH, Chang JW, Shin YS, Kim KI, Park JK, Yang SS, Lee JS et al (2014) Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species. Cell Death Dis 5:e1056. doi:10.1038/cddis.2014.33
Adhihetty PJ, O'Leary MF, Hood DA (2008) Mitochondria in skeletal muscle: adaptable rheostats of apoptotic susceptibility. Exerc Sport Sci Rev 36(3):116–121. doi:10.1097/JES.0b013e31817be7b7
Reissig JL, Storminger JL, Leloir LF (1955) A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem 217(2):959–966
Hamann S, Metrailler S, Schorderet DF, Cottet S (2013) Analysis of the cytoprotective role of alpha-crystallins in cell survival and implication of the alphaA-crystallin C-terminal extension domain in preventing Bax-induced apoptosis. PLoS One 8(2):e55372. doi:10.1371/journal.pone.0055372
Acknowledgments
We thank Prof. Alok Bhattacharya (School of Life Sciences, Jawaharlal Nehru University, and New Delhi) for thoughtful discussions and progressive comments during the project. This work was supported by grants from the Indian Council of Medical Research, India and Council of Scientific and Industrial Research, Govt. of India. We acknowledge Mr. Ashok and Mr. Prabhat Advanced Instrumentation Research Facility (AIRF), Jawaharlal Nehru University, New Delhi, for technical assistance in confocal microscopy and live cell imaging. We acknowledge Dr. Anwar Alam and Mrs. Sarika (School of Life Sciences, Jawaharlal Nehru University, NewDelhi) for technical assistance in flow cytometry.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Figure S1
Determination of DNA damage/nuclear fragmentation by TUNEL assay after supplementation with 5 mM NANA: Representative image of wtGNE and GNE mutants obtained by confocal microscopy, depicting DNA damage/nuclear fragmentation by TUNEL assay. Arrows indicate TUNEL-positive cells (green).The images were viewed using Olympus Fluoview FV1000 laser scan at 60 X magnification. (JPEG 85 kb)
Figure S2
Study of cell apoptosis by Annexin V-FITC/Propidium iodide staining after supplementation with 5 mM NANA: Annexin V-FITC and Propidium iodide staining of wtGNE and different GNE mutant cells were analyzed by flow cytometry after NANA supplementation. B.Graphical representation of fold changein apoptosis of various GNE mutant cells compared to wtGNE cell line. (JPEG 111 kb)
Figure S3
Effect of GNE mutation on mitochondrial dysfunction after 5 mM NANA supplementation: A. Effect of GNE mutation on dissipation of mitochondrial membrane potential (as measured by JC-1) using confocal microscopy, magnification 60 X. B. Histogram shows the ratio of red to green fluorescence intensity observed in various cell lines characterizing Δψ (m). (JPEG 145 kb)
Rights and permissions
About this article
Cite this article
Singh, R., Arya, R. GNE Myopathy and Cell Apoptosis: A Comparative Mutation Analysis. Mol Neurobiol 53, 3088–3101 (2016). https://doi.org/10.1007/s12035-015-9191-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9191-5